Study looks at what predicts lymph node spread in uterine cancer
Part of Cancer, Women’s health & pregnancy clinical trials.
This study uses tumor tissue and genetic test results to understand which features predict whether lymph nodes (sentinel nodes) are cancer-positive in endometrial (uterine) cancer. It mainly helps doctors improve how they predict spread and tailor care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must agree to take part by signing informed consent
- You have confirmed endometrial (uterine) cancer based on tissue testing
- You have available results from genetic/tumor profiling (such as POLE, p53 changes, MMRd/MSI-H, or NSMP)
- You have information from the tumor’s lab features and a sentinel node mapping was done
- Your sentinel lymph node test result is known as negative or positive
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether very small deposits of cancer (called micrometastasis or isolated tumor cells) are found in sentinel lymph nodes in early endometrial or cervical cancer. The goal is to better understand what these findings may mean for cancer spread and treatment planning.
This trial studies how to find the “sentinel” (first) lymph node during surgery for high-risk endometrial (uterine) cancer. It may help surgeons better tell whether cancer has spread to nearby lymph nodes and guide the extent of lymph node removal.
This trial tests whether removing only the first lymph node to detect cancer spread (sentinel node mapping) is as effective as removing all lymph nodes in the pelvic area (comprehensive lymphadenectomy) for a specific type of endometrial cancer with a p53 mutation, stages I–II. The goal is to see if the less extensive surgery can result in similar outcomes while possibly reducing side effects.
This study compares two ways to check lymph nodes during surgery for early-stage endometrial (uterine) cancer: sentinel node biopsy versus removing more lymph nodes. It may help find whether the less extensive approach can stage the cancer accurately with fewer side effects.
This trial looks at better ways to predict how aggressive your endometrial cancer is before surgery, so doctors can decide if they need to check your lymph nodes. It may help tailor your treatment to avoid unnecessary procedures.
This is an observational study that follows people with endometrial cancer who have had surgery to check and remove pelvic (and sometimes paraaortic) lymph nodes. It looks at how different surgical approaches and any added treatment affect local control (keeping cancer from coming back in the pelvis/nearby areas).
Hear when a new Endometrial Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.